Rafeeq Profile
Rafeeq

@rafeeq_rm

Followers
1K
Following
5K
Media
182
Statuses
8K

Paediatric gastroenterologist, past Chair of IBD WG of BSPGHAN(2017-2020), Past Chair of Education WG of BSPGHAN loves reading, travelling and sports

Birmingham, England
Joined June 2014
Don't wanna be here? Send us removal request.
@rafeeq_rm
Rafeeq
7 years
These cakes were brought by my 18 year old patient with #Crohn’s disease. It was his last appointment at the Children’s Hospital.I have looked after him for~5 years,he is in deep remission. #IBD management is team work. Thx to staff @Bham_Childrens @CrohnsColitisUK @CICRAcharity
Tweet media one
2
19
188
@rafeeq_rm
Rafeeq
47 minutes
RT @NICEComms: 📢 @NICEComms and @MHRAgovuk announce joint working plans to speed up medicine approvals as part of the #10YearHealthPlan.….
0
6
0
@rafeeq_rm
Rafeeq
1 day
RT @NarulaNeeraj: 🚨Out now @AmJGastro: Ultra-Processed Grains and Risk of Inflammatory Bowel Disease: Results from the Prospective Urban Ru….
0
15
0
@rafeeq_rm
Rafeeq
1 day
RT @DrAnuraagJ: Efficacy and Safety of Vedolizumab & Tofacitinib (VETO) Combination Therapy in Refractory UC Unresponsive to Anti-TNF and S….
0
17
0
@rafeeq_rm
Rafeeq
3 days
RT @pash22: Unintended consequences: quantifying the benefits, iatrogenic harms and downstream cascade costs of musculoskeletal MRI in UK p….
0
7
0
@rafeeq_rm
Rafeeq
4 days
RT @TheAtlantic: Vinay Prasad, one of the country’s top FDA medical regulators, was supposed to be the guy who kept Big Pharma in check, @B….
Tweet card summary image
theatlantic.com
Vinay Prasad was supposed to be the guy who kept Big Pharma in check. Now he’s gone.
0
8
0
@rafeeq_rm
Rafeeq
5 days
RT @HilarHolzy: 💡Complications related to endoscopic procedures have a profound impact on the endoscopist. Unfortunately, this tends to be….
0
34
0
@rafeeq_rm
Rafeeq
6 days
RT @RuneWilkens: Finally, the new ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease:….
Tweet card summary image
academic.oup.com
Abstract. The current consensus guideline offers a comprehensive and practical guidance on the diagnostic and monitoring of patients with inflammatory bowe
0
27
0
@rafeeq_rm
Rafeeq
14 days
RT @pash22: Exploring the earnings of @NHSEngland doctors (2025 update).via @Billy_Palmer_ et al & @NuffieldTrust h….
0
2
0
@rafeeq_rm
Rafeeq
15 days
RT @LancetGastroHep: New research - Anti-TL1A antibody, afimkibart, in moderately-to-severely active ulcerative colitis (TUSCANY-2): a mult….
0
14
0
@rafeeq_rm
Rafeeq
15 days
RT @MN_GIMD: Let’s talk prep baby! Apologies to my fellows for embarrassing them with that joke! 🙃. But this is an important topic! . ✅ Iso….
0
26
0
@rafeeq_rm
Rafeeq
16 days
RT @Rheumat_Aravind: 🧵 GI Endoscopy Findings in Rheumatology – A Visual Thread. Autoimmune diseases often leave visible footprints in the g….
0
30
0
@rafeeq_rm
Rafeeq
16 days
RT @ASSIST_IBD: Research opportunity for UK teens with Crohn's or Colitis! . We've developed a new web support programme, ASSIST-IBD to….
0
3
0
@rafeeq_rm
Rafeeq
18 days
RT @Bealoquebea: GALAXI 2 and 3 trials of guselkumab maintenance in patients with Crohns disease just published. 🌟Guselkumab superior to pl….
0
36
0
@rafeeq_rm
Rafeeq
18 days
RT @ibdtweets: 🎯 Extending the Half-Life of mAbs: Why It Matters in IBD. In Crohn’s disease and ulcerative colitis, therapeutic monoclonal….
0
20
0
@rafeeq_rm
Rafeeq
22 days
RT @IBDNathan: Nice to see our propensity-weighted comparison of first-line vedolizumab and tofacitinib is now published. We found that the….
Tweet card summary image
academic.oup.com
AbstractBackground and Aims. Over the last decade, treatment options for moderate-to-severe ulcerative colitis (UC) have expanded. However, comparative stu
0
10
0
@rafeeq_rm
Rafeeq
26 days
RT @drvishal82: Our scoping review on use of Wearable technologies in #IBD now published in @AGA_CGH . Suggests increasing role in .- earl….
0
23
0
@rafeeq_rm
Rafeeq
26 days
RT @han_francis: You don’t have to actually worry about Pfizer’s delaying their vaccine myocarditis study until 2030. I’m a cardiologist -….
0
47
0
@rafeeq_rm
Rafeeq
26 days
RT @charlie_lees: Eight clinical trials to watch in IBD . (extracted from the latest edition of Atomic IBD). 1. TL1A Inhibition — The Next….
0
37
0